Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05616546 · ClinicalTrials.gov registry record · Phase 4

Bone Marrow and Peripheral Blood Immune Responses Study

A Phase 4 study of Influenza, sponsored by Emory University.

Recruiting
Registry status
Phase 4
Development phase
90
Enrollment target
1
Study location

NCT05616546 is a Phase 4 study of Influenza that is actively recruiting participants, run by Emory University. The registered enrollment target is 90 participants, below the 36,803-participant average among 156 other Influenza trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05616546, a Phase 4 study of Influenza, is actively recruiting participants, sponsored by Emory University.

RECRUITING
Registry status
Phase 4
Development phase
90 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to evaluate the immune response of the killed flu vaccine in healthy subjects. Participants in this study are considered to be healthy volunteers. Influenza ("Flu") infection carries a risk of serious illness. This is an open label and single arm observational study designed to assess the humoral response to influenza vaccination and the longevity of humoral immunity to influenza vaccination in healthy adults. Enrolled subjects will receive licensed seasonal inactivated influenza vaccine (administered as a part of the study). Participants will donate serial samples of blood and bone marrow aspirate for immunology monitoring. Repeated measurements of humoral immunity will be obtained at 7 days, 28 days, 90 days and at one year post vaccination to assess the magnitude, clonal diversity and persistence of B-cell responses to influenza vaccination.

Conditions Studied

Influenza

Interventions

  • BIOLOGICAL Influenza Vaccine

Study Locations (1)

Georgia

  • Emory University Hospital - Atlanta

Trial Details

FieldValue
Enrollment Target 90 participants
Start Date 2023-10-16
Est. Completion 2029-12
Phase Phase 4

Sponsor

Emory University

1,208 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05616546

The ClinicalTrials.gov registry entry for NCT05616546 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 36,803-participant average among 156 other Influenza trials with a reported enrollment target (100% lower). The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Influenza appearing as the primary indexed condition, and to 1 intervention - of which Influenza Vaccine is the first listed.

NCT05616546 reports 1 study location spanning 1 distinct geographic area - top geographies include Georgia.

Frequently Asked Questions

What is clinical trial NCT05616546 about?

NCT05616546 is a clinical study titled "Bone Marrow and Peripheral Blood Immune Responses Study". The purpose of this study is to evaluate the immune response of the killed flu vaccine in healthy subjects. Participants in this study are considered to be healthy volunteers. Influenza ("Flu") infection carries a risk of serious illness. This is an open label and single arm observational study des...

What is the current status of trial NCT05616546?

This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 90 participants. The study started on 2023-10-16. Estimated completion is 2029-12.

What conditions does trial NCT05616546 study?

This clinical trial studies the following conditions: Influenza.

What interventions are being tested in trial NCT05616546?

The interventions under investigation include: Influenza Vaccine (BIOLOGICAL).

Who is sponsoring clinical trial NCT05616546?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05616546 being conducted?

This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Influenza

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Influenza

All registered trials for this condition

Georgia

All trials with a study site in Georgia

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.